Status:
UNKNOWN
Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Collaborating Sponsors:
Centre Hospitalier Victor Dupouy
Conditions:
Covid19
Ventilator Associated Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
A Respiratory infection with the SARS-CoV2 virus is associated with a major risk of viral pneumonia that can lead to respiratory distress requiring resuscitation. In the most severe forms, it may requ...
Detailed Description
Patients requiring invasive mechanical ventilation are at risk of secondary, nosocomial, a hospitalization in the ICU service and can affect up to 40% of ventilated patients. The occurrence of ventila...
Eligibility Criteria
Inclusion
- Patient whose age ≥ 18 years old
- French-speaking patient
- Patient whose COVID-19 infection was diagnosed by either a laboratory test, PCR or any other commercial or public health test.
- Adult acute respiratory distress syndrome according to the Berlin definition
- Pneumonia acquired under mechanical ventilation defined according to the criteria of international companies
Exclusion
- Patient/family or proxy opposing participation in the study
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under the safeguard of justice.
Key Trial Info
Start Date :
September 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04488510
Start Date
September 11 2020
End Date
April 30 2023
Last Update
March 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014